Categories: Business

OMRON Releases the Medium-Term Roadmap SF 2nd Stage

KYOTO, Japan–(BUSINESS WIRE)–OMRON (TOKYO: 6645) has announced its “Medium-Term Roadmap Shaping the Future 2nd Stage (“SF 2nd Stage”),” covering from FY2026 to FY2030, on November 7, 2025 (JST). This Roadmap presents the Group’s vision and growth strategies through 2030, which are disclosed on our corporate website.

- Advertisement -


- Advertisement -

Overview of the “Medium-Term Roadmap SF 2nd Stage”

- Advertisement -

Since April 2024, OMRON has been implementing a Structural Reform Program “NEXT 2025” aimed at rebuilding our foundation for profitability and growth. With the completion of this Program in September 2025, we have shifted into a growth phase and formulated a new Roadmap looking ahead to 2030.

- Advertisement -

This Roadmap identifies Business Portfolio Restructuring as a core strategy. We have defined Thirteen Focus Businesses to drive the Group’s future growth. By accelerating our selection and concentration efforts, we aim to build a “distinctive” business portfolio that maximizes overall Group growth. Furthermore, to maximize the growth potential of our Focus Businesses, we will drive transformation decisively across three areas, “VALUE”, “FRONT”, and “Resource Allocation.”

- Advertisement -

Building on the profit foundation established through Structural Reform Program, we will thoroughly enhance our business growth capabilities and aim to increase corporate value through sustainable, profit-driven growth.

- Advertisement -

Related Information

- Advertisement -

Medium-Term Roadmap SF 2nd Stage

- Advertisement -

About OMRON

- Advertisement -

OMRON Corporation, as a leading automation company centered on its unique “Sensing & Control + Think” technology, develops businesses in Factory Automation, Healthcare, Social systems, Device and module, and Data solutions that utilize a wide variety of data acquired through these businesses. Founded in 1933, OMRON now employs about 27,000 people worldwide, provides products and services in more than 130 countries, and contributes to the creation of a better society.

Please visit the OMRON website for additional information.

- Advertisement -

Contacts

- Advertisement -

Investor Relations Department

OMRON Corporation

E-Mail: omron-ir@omron.com

- Advertisement -
Business Wire

Published by
Business Wire

Recent Posts

Kunming Is Becoming Chinas Top Destination City for Inbound Consumption

KUNMING, China--(BUSINESS WIRE)--Positioned at the crossroads of the China–ASEAN Free Trade Area and the Greater…

2 hours ago

Novo Nordisk will not increase its proposal to acquire Metsera, Inc.

Bagsværd, Denmark, 8 November 2025 – Novo Nordisk today confirms that it does not intend to…

3 hours ago

Fangzhou Awarded Golden Bull Award for Leadership in AI-Powered Chronic Disease Management

XIAMEN, China, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX:…

3 hours ago

Senores Pharma Reports Strong Q2 & H1 FY26 Performance, Sustains Growth Momentum Across Businesses

AHMEDABAD, India, Nov. 7, 2025 /PRNewswire/ -- Senores Pharmaceuticals Limited continued its strong growth trajectory in…

3 hours ago

Elevaris Introduces CDMO Services, Procedural Needle Portfolio to EMEA

Company Leverages Legacy of Trust and Expertise as it Makes Inaugural Appearance at COMPAMED/MEDICA BOSTON,…

3 hours ago

Cell Impact and thyssenkrupp Automation Engineering have entered a cooperation agreement

KARLSKOGA, Sweden, Nov. 6, 2025 /PRNewswire/ -- Cell Impact and thyssenkrupp Automation Engineering have entered a Strategic…

3 hours ago